To determine whether the treatment of GBM cell lines with DAC would alter the expression of ACTL8, CTCFL, OIP5 and XAGE3, two GBM cell lines were treated with 5μM DAC, the mRNA extracted and RT-PCR performed. The gene discussed is CTCFL; the disease is glioblastoma.